Urine metabolomics has recently emerged as a prominent field for the discovery of non‐
invasive biomarkers that can detect subtle metabolic discrepancies in response to a specific …

Metabolism of bladder cancer represents a key issue for cancer research. Several metabolic
altered pathways are involved in bladder tumorigenesis, representing therefore interesting …

Metabolic reprogramming is a hallmark of cancer. However, systematic characterizations of
metabolites in triple-negative breast cancer (TNBC) are still lacking. Our study profiled the …

Current clinical practices focus on a small number of biochemical directly related to the
pathophysiology with patients and thus only describe a very limited metabolome of a patient …

Urinary tests have been used as noninvasive, cost-effective tools for screening, diagnosis
and monitoring of diseases since ancient times. As we progress through the 21st century …

Bladder cancer (BC) is the tenth most commonly diagnosed malignancy worldwide. In
approximately 25% of cases, it presents as a muscle-invasive disease, requiring a radical …

Metabolomic analysis has proven to be a useful tool in biomarker discovery and the
molecular classification of cancers. In order to find new biomarkers, and to better understand …

Tumor metabolism is reorganized to support proliferation in the face of growth-related stress.
Unlike the widespread profiling of changes to metabolic enzyme levels in cancer …

Amyloid plaques in Alzheimer's disease (AD) are associated with inflammation. Recent
studies demonstrated the involvement of the gut in cerebral amyloid-beta (Aβ) pathogenesis; …

Diabetes is characterized by altered metabolism of key molecules and regulatory pathways.
The phenotypic expression of diabetes and associated complications encompasses …